SEC Info - Aveanna Healthcare Holdings, Inc. - ‘10-Q’ for 4/2/22

SEC Info℠

Home

Help

Please Sign In

Aveanna Healthcare Holdings, Inc. – ‘10-Q’ for 4/2/22 – ‘EX-101.SCH’

On: Wednesday, 5/11/22, at 4:17pm ET · For: 4/2/22 · Accession #: 950170-22-9347 · File #: 1-40362

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/11/22  Aveanna Healthcare Holdings, Inc. 10-Q        4/02/22   63:7.1M                                   Donnelley … Solutions/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    744K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
11: R1          Document and Entity Information                     HTML     71K 
12: R2          Consolidated Balance Sheets                         HTML    137K 
13: R3          Consolidated Balance Sheets (Parenthetical)         HTML     39K 
14: R4          Consolidated Statements of Operations (Unaudited)   HTML     88K 
15: R5          Consolidated Statements of Stockholders' Equity     HTML     42K 
16: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    126K 
17: R7          Description of Business                             HTML     23K 
18: R8          Summary of Significant Accounting Policies          HTML     29K 
19: R9          Revenue                                             HTML     60K 
20: R10         Long-Term Obligations                               HTML     89K 
21: R11         Securitization Facility                             HTML     30K 
22: R12         Fair Value Measurements                             HTML     74K 
23: R13         Derivative Financial Instruments                    HTML     45K 
24: R14         Income Taxes                                        HTML     28K 
25: R15         Share-Based Compensation                            HTML     50K 
26: R16         Commitments and Contingencies                       HTML     50K 
27: R17         Covid-19                                            HTML     44K 
28: R18         Related Party Transactions                          HTML     26K 
29: R19         Segment Information                                 HTML    131K 
30: R20         Net Income Per Share                                HTML     60K 
31: R21         Summary of Significant Accounting Policies          HTML     37K 
                (Policies)                                                       
32: R22         Revenue (Tables)                                    HTML     45K 
33: R23         Long-Term Obligations (Tables)                      HTML     69K 
34: R24         Fair Value Measurements (Tables)                    HTML     70K 
35: R25         Derivative Financial Instruments (Tables)           HTML     33K 
36: R26         Segment Information (Tables)                        HTML    125K 
37: R27         Net Income Per Share (Tables)                       HTML     58K 
38: R28         Description of Business - Additional Information    HTML     20K 
                (Details)                                                        
39: R29         Revenue - Additional Information (Detail)           HTML     26K 
40: R30         Revenue - Schedule of Revenue by Payer Type as a    HTML     34K 
                Percentage of Revenue (Detail)                                   
41: R31         Acquisitions - Additional Information (Details)     HTML     24K 
42: R32         Acquisitions - Summary of Preliminary Purchase      HTML     21K 
                Price Allocations (Details)                                      
43: R33         Long-Term Obligations - Schedule of Long-Term       HTML     54K 
                Obligations and Notes Payable (Details)                          
44: R34         Long-Term Obligations - Schedule of Long-Term       HTML     26K 
                Obligations and Notes Payable (Parenthetical)                    
                (Details)                                                        
45: R35         Long-Term Obligations - Additional Information      HTML     82K 
                (Details)                                                        
46: R36         Securitization Facility - Additional Information    HTML     34K 
                (Details)                                                        
47: R37         Fair Value Measurements - Summary of Other Assets   HTML     36K 
                and Other Liabilities Measured at Fair Value                     
                (Details)                                                        
48: R38         Derivative Financial Instruments - Additional       HTML     49K 
                Information (Details)                                            
49: R39         Derivative Financial Instruments - Schedule of      HTML     26K 
                Gains from Derivatives (Details)                                 
50: R40         Income Taxes - Additional Information (Detail)      HTML     27K 
51: R41         Share-Based Compensation - Additional Information   HTML     66K 
                (Details)                                                        
52: R42         Commitments and Contingencies - Additional          HTML     59K 
                Information (Details)                                            
53: R43         Covid-19 - Additional Information (Detail)          HTML     64K 
54: R44         Related Party Transactions - Additional             HTML     26K 
                Information (Details)                                            
55: R45         Segment Information - Additional Information        HTML     23K 
                (Details)                                                        
56: R46         Segment Information - Summary of Segment            HTML     45K 
                Information (Details)                                            
57: R47         Segment Information - Summary of Segment            HTML     52K 
                Reconciliation (Details)                                         
58: R48         Net Income Per Share - Summary of Computation of    HTML     60K 
                Basic and Diluted Net Income Per Share (Detail)                  
61: XML         IDEA XML File -- Filing Summary                      XML    109K 
59: XML         XBRL Instance -- avah-20220402_htm                   XML   1.30M 
60: EXCEL       IDEA Workbook of Financial Reports                  XLSX     70K 
 6: EX-101.CAL  XBRL Calculations -- avah-20220402_cal               XML    181K 
 8: EX-101.DEF  XBRL Definitions -- avah-20220402_def                XML    537K 
10: EX-101.LAB  XBRL Labels -- avah-20220402_lab                     XML   1.17M 
 9: EX-101.PRE  XBRL Presentations -- avah-20220402_pre              XML    800K 
 7: EX-101.SCH  XBRL Schema -- avah-20220402                         XSD    162K 
62: JSON        XBRL Instance as JSON Data -- MetaLinks              349±   515K 
63: ZIP         XBRL Zipped Folder -- 0000950170-22-009347-xbrl      Zip    235K

‘EX-101.SCH’ — XBRL Schema — avah-20220402

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema targetNamespace="http://www.aveanna.com/20220402" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:avah="http://www.aveanna.com/20220402" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>

<xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4"/>

<xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avah-20220402_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avah-20220402_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avah-20220402_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avah-20220402_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>

<link:roleType roleURI="http://www.aveanna.com/20220402/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">

<link:definition> 100000 - Document - Document and Entity Information </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>